Question 1

How many institutions own PTHS stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PTHS shares is 7, representing 10.43% of the company's common stock.

Question 2

Who are the major shareholders selling Pelthos Therapeutics Inc. stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in PTHS by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the PTHS shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned PTHS shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying PTHS stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in PTHS by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of PTHS to its portfolio, raising its holding to - shares of worth -. N/A also increased its PTHS shares holding by N/A which brought its holding to - shares worth -.

Question 4

PTHS's major insiders: who are they?

Accepted Answer

The insider with the most stakes in PTHS is Friedberg Ezra M , director at the company. Additionally, PTHS stock is highly held by director Malamut Richard and director Greenleaf Peter among others.

Question 5

Did an insider recently sell PTHS stock?

Accepted Answer

Company executives, directors, and other insiders own 64.2% percent of Pelthos Therapeutics Inc.'s stock. Within the last six months, there have been 5 transaction(s) in which PTHS insiders have sold stock, totaling 3.29K shares. Insiders that have sold shares include MALAMUT RICHARD, FRIEDBERG EZRA M, and PAULS MATTHEW.

Question 6

Which insider recently purchased PTHS stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Pelthos Therapeutics Inc. insiders have bought stock, totalling 0 shares

Question 7

How much of PTHS does insiders own?

Accepted Answer

Around 179.28K Pelthos Therapeutics Inc. shares are held by insiders, which represents about 64.2% of PTHS stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

PTHS director, Friedberg Ezra M holds the largest portfolio of the company's shares. PTHS shares owned by Friedberg total nearly 82.03 thousand.

Question 9

Which institution holds the most shares in PTHS?

Accepted Answer

N/A is the largest institutional owner in PTHS which holds - shares worth - or N/A of the total PTHS shares outstanding followed by N/A with ownership of - shares representing N/A of the PTHS ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is Pelthos Therapeutics Inc. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PTHS is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on PTHS's shares?

Accepted Answer

Number of PTHS shares short is 4.79K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding PTHS shares are there?

Accepted Answer

As of today, 648.50K shares of PTHS are outstanding.

Question 13

Is there many float in PTHS stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PTHS has 616.46K shares in float.

Question 14

PTHS short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PTHS is 0.03.

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Apr 02, 2026	MALAMUT RICHARD	SALE	21.36	280	5.98K	27.42K
Apr 02, 2026	FRIEDBERG EZRA M	SALE	21.36	265	5.66K	82.03K
Apr 02, 2026	PAULS MATTHEW	SALE	21.36	371	7.93K	15.15K
Apr 02, 2026	GREENLEAF PETER	SALE	21.36	377	8.05K	24.68K
Nov 25, 2025	FRIEDBERG EZRA M	SALE	28.00	2K	56.01K	30K
Jul 01, 2025	FRIEDBERG EZRA M	PURCHASE	10.00	40K	400K	40K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Apr 02, 2026	MALAMUT RICHARD	SALE	21.36	280	5.98K	27.42K
Apr 02, 2026	FRIEDBERG EZRA M	SALE	21.36	265	5.66K	82.03K
Apr 02, 2026	PAULS MATTHEW	SALE	21.36	371	7.93K	15.15K
Apr 02, 2026	GREENLEAF PETER	SALE	21.36	377	8.05K	24.68K
Nov 25, 2025	FRIEDBERG EZRA M	SALE	28.00	2K	56.01K	30K
Jul 01, 2025	FRIEDBERG EZRA M	PURCHASE	10.00	40K	400K	40K

PTHS Stock Ownership Breakdown

Pelthos Therapeutics

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions